84 related articles for article (PubMed ID: 35417479)
1. VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300.
Guo S; Hu X; Cotton JL; Ma L; Li Q; Cui J; Wang Y; Thakare RP; Tao Z; Ip YT; Wu X; Wang J; Mao J
bioRxiv; 2024 May; ():. PubMed ID: 38746415
[TBL] [Abstract][Full Text] [Related]
2. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Graham K; Lienau P; Bader B; Prechtl S; Naujoks J; Lesche R; Weiske J; Kuehnlenz J; Brzezinka K; Potze L; Zanconato F; Nicke B; Montebaur A; Bone W; Golfier S; Kaulfuss S; Kopitz C; Pilari S; Steuber H; Hayat S; Kamburov A; Steffen A; Schlicker A; Buchgraber P; Braeuer N; Font NA; Heinrich T; Kuhnke L; Nowak-Reppel K; Stresemann C; Steigemann P; Walter AO; Blotta S; Ocker M; Lakner A; von Nussbaum F; Mumberg D; Eis K; Piccolo S; Lange M
Cell Chem Biol; 2024 Mar; ():. PubMed ID: 38537632
[TBL] [Abstract][Full Text] [Related]
3. Simplifying cancer: binary pan-cancer superclasses stratified by opposite YAP/TEAD effects.
Pearson JD; Bremner R
Mol Cell Oncol; 2021; 8(5):1981111. PubMed ID: 34859143
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells.
Sun Y; Hu L; Tao Z; Jarugumilli GK; Erb H; Singh A; Li Q; Cotton JL; Greninger P; Egan RK; Tony Ip Y; Benes CH; Che J; Mao J; Wu X
Nat Commun; 2022 Nov; 13(1):6744. PubMed ID: 36347861
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.
Laraba L; Hillson L; de Guibert JG; Hewitt A; Jaques MR; Tang TT; Post L; Ercolano E; Rai G; Yang SM; Jagger DJ; Woznica W; Edwards P; Shivane AG; Hanemann CO; Parkinson DB
Brain; 2023 Apr; 146(4):1697-1713. PubMed ID: 36148553
[TBL] [Abstract][Full Text] [Related]
6. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present).
Zagiel B; Melnyk P; Cotelle P
Expert Opin Ther Pat; 2022 Aug; 32(8):899-912. PubMed ID: 35768160
[TBL] [Abstract][Full Text] [Related]
7. Insights into recent findings and clinical application of YAP and TAZ in cancer.
Franklin JM; Wu Z; Guan KL
Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.
Seavey CN; Pobbati AV; Rubin BP
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740643
[TBL] [Abstract][Full Text] [Related]
9. Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive
Nouri K; Azad T; Ling M; Janse van Rensburg HJ; Pipchuk A; Shen H; Hao Y; Zhang J; Yang X
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635084
[TBL] [Abstract][Full Text] [Related]
10. Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex.
Che K; Pobbati AV; Seavey CN; Fedorov Y; Komar AA; Burtscher A; Ma S; Rubin BP
PLoS One; 2022; 17(4):e0266143. PubMed ID: 35417479
[TBL] [Abstract][Full Text] [Related]
11. Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex.
Pobbati AV; Rubin BP
Molecules; 2020 Dec; 25(24):. PubMed ID: 33352993
[TBL] [Abstract][Full Text] [Related]
12. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
Elife; 2021 Apr; 10():. PubMed ID: 33913810
[TBL] [Abstract][Full Text] [Related]
13. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
Crawford JJ; Bronner SM; Zbieg JR
Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
[No Abstract] [Full Text] [Related]
14. Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
Sturbaut M; Bailly F; Coevoet M; Sileo P; Pugniere M; Liberelle M; Magnez R; Thuru X; Chartier-Harlin MC; Melnyk P; Gelin M; Allemand F; Guichou JF; Cotelle P
Eur J Med Chem; 2021 Dec; 226():113835. PubMed ID: 34509860
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
